Call us directly: 1-818-646-1414

800 S. Central Ave., Unit 307 View Location


Chilingaryan A, Chilingaryan AM, Chilingaryan M, Martin GG. 2014. Three-Dimensional Microvasculature in Rat and Human Hearts Using a Non-injection Ca2+-ATPase Method on Thick and Ultra-Thick Sections. Microsc Microanal. 20(3):895-902

Martin G.G., Simcox R., Nguyen A., Chilingaryan A. 2006. Peritrophic membrane of the penaeid shrimp Sicyonia ingentis: structure, formation, permeability. Biol. Bull. 211: 275-285.

Chilingaryan A., Chilingaryan A.M., Martin G.G. 2006. The three-dimensional detection of microvasculatory bed in the brain of white rat Rattus norvegicus by a Ca2+-ATPase method. Brain Research 1070: 131-138.


Hui Gong, Amaiak Chilingaryan,Grigor Harutunian, Nazely Ashikian, Said Beydoun Characteristics and Differential Diagnosis of Neuropathy in a Tertiary Neuromuscular Clinic. Poster Session IV: Neuromuscular: Electrodiagnostic. American Academy of Neurology, 66th Annual Meeting, April 30, 2014.

Chilingaryan A., Chilingaryan A.M, Miller C.A. “A Novel Non-injectional Method of Three-Dimensional Staining of Human Central Nervous System Microvasculature Using Cadmium.” Poster Session P05. American Academy of Neurology, 65th Annual Meeting, San Diego, CA, March 20, 2013.

Chilingaryan A., Chilingaryan A.M, Miller C.A. “A Novel Lead Technique for Studying the Neuronal Organization of the Brain." Poster Session P04. American Academy of Neurology, 65th Annual Meating,San Diego, CA, March 20, 2013.

Chilingaryan A. Ramos-Platt L. 17 year old male with hyperreflexia and weakness. J of Clin. Neuromuscul. Dis. 2012. 34th Annual Carrell-Krusen Neuromuscular Symposium, Dallas, TX in 2012.

Clinical Trials

Sub-Investigator for - Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investigate the efficacy, safety, and tolerability of 2 different doses of IgPro20 (subcutaneous immunoglobulin) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) – the PATH study- Jan 2013-June 2014

Sub-investigator for - Phase 3 Double Blind, Randomized, Placebo controlled Safety and Efficacy of once daily controlled release Pregabalin in the treatment of patients with Post Herpetic Neuralgia (Protocol A0081224)-Sep 2013-June 2014

Sub-Investigator for - A Randomized, Double Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of Pregabalin (BID) in Subjects with Post-Traumatic Peripheral Neuropathic Pain, 2013- June 2014

Sub-Investigator for - A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients with Post-Herpetic Neuralgia (PHN) 2013-May 2014.

Sub-Investigator for - A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG) - April 2014- June 2014

+1 818 646 1414

...or fill in the form on our Appointments page: